Kropotova Alexandra 4
4 · SAB Biotherapeutics, Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Kropotova Alexandra
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2023-03-14+275,000→ 275,000 total
Footnotes (2)
- [F1]Restricted Stock Unit ("RSU") award under the 2021 Equity Incentive Plan, which vests over a four-year service period, with the first 25% vesting on March 14, 2024, and the remaining vesting in even monthly increments thereafter. The RSU award is subject to the reporting person's continued employment through the vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.